SCHEMBL5205796

SCHEMBL5205796

CC(c1ccc(Cl)cc1)C(CNC(=O)C1CCCC(C(=O)c2ccccc2)C1)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
RECQL P46063 1/20 0.39
MGLL Q99685 1/20 0.39
CCR1 P32246 2/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
TP53 P04637 1/20 0.38
KCNH2 Q12809 1/20 0.38
CCR5 P51681 1/20 0.37
KDM2B Q8NHM5 1/20 0.37
SLC6A2 P23975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206255 0.96 MEN1 (0.41) HPGDGAASMN1; SMN2MEN1KMT2A
SCHEMBL5200515 0.89 MGLL (0.44) HPGDGAASMN1; SMN2MEN1KMT2A
SCHEMBL4825560 0.80 CNR1 (0.50) HPGDGAASMN1; SMN2
SCHEMBL5201372 0.77 CNR1 (0.49) HPGDGAASMN1; SMN2
SCHEMBL5205656 0.76 SIGMAR1 (0.52) ALDH1A1
SCHEMBL5262774 0.76 SLC6A9 (0.54) GAASMN1; SMN2MEN1KMT2ATP53
SCHEMBL4829860 0.75 CNR1 (0.52)
SCHEMBL5200358 0.75 SMN1; SMN2 (0.41) HPGDGAASMN1; SMN2MEN1KMT2A
SCHEMBL5201159 0.73 PKM (0.48) HPGDGAASMN1; SMN2ALDH1A1
SCHEMBL5479926 0.72 PRMT5 (0.42) HPGDGAASMN1; SMN2DRD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP claimed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP claimed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO claimed